D. K. Helgeson

Phase 2 Trial of Ixazomib, Cyclophosphamide and Dexamethasone for Treatment of Previously Untreated Light Chain Amyloidosis

P. L. Bergsagel, D. Dingli, A. Dispenzieri, 2020 .

Phase 2 trial of ixazomib, cyclophosphamide, and dexamethasone for previously untreated light chain amyloidosis

D. Dingli, A. Dispenzieri, Shaji K. Kumar, 2022, Blood Advances.